Acadia Pharmaceuticals Inc (ACAD) Stock Forecast & Predictions

Acadia Pharmaceuticals Inc ACAD: $20.615

3611 Valley Centre Dr Ste 300, San Diego, California, US. | Sector: Manufacturing | Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET) | Web: http://www.acadia-pharm.com/

  • Market Cap$3.44B
  • Change (52 Weeks)-56.55%
  • Low (52 Weeks)$20.12
  • Acadia Pharmaceuticals Inc (ACAD) Forecast Based on Technical Analysis


    Neutral
    Based on 16 Technical Indicators where 0.00% are on Buy, 50.00% on Sell, and 50.00% Neutral.

    According to the market data, Acadia Pharmaceuticals Inc (ACAD) stock price is $20.615 and the 52 weeks low is $20.12, which means the Acadia Pharmaceuticals Inc stock price is down -56.55% in the last 12 months.

    Acadia Pharmaceuticals Inc (ACAD) Stock Price has been Trending Strongly with an ADX reading of 35.73 as per the Weekly Chart.

    A Upward trend indicates that Acadia Pharmaceuticals Inc (ACAD) Stock Price may keep going up, with temporary Retracement (the process of stock price bouncing because of short term profit taking by the traders and investors).

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 0.00% are indicating that ACAD Stock price might rise further, 50.00% indicating that ACAD Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall ACAD stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Acadia Pharmaceuticals Inc (ACAD) Stock Forecast By Analysts


    Strong Buy
    Analysts Recommendations for Acadia Pharmaceuticals Inc (ACAD) is based on 25 Institutional Analyst Ratings where 52.00% are on Strong Buy, 20.00% on Moderate Buy, 28.00% remains on Hold, 0.00% are on Moderate Sell and 0.00% are on Strong Sell.

    Out of 25 Institutional Analysts, majority recommended ACAD stock as Strong Buy. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Acadia Pharmaceuticals Inc.

    Acadia Pharmaceuticals Inc (ACAD) Stock Price Prediction By Analysts


    HighLowAverage
    $73.50$18.18$30.03
    $30.0345.69% Upside
    Updated: 2021-04-22 00:00:00

    The Average Price target for ACAD set by the institutional analysts is $30.03 where High Estimate is $73.50, Median $27.03 and Low $18.18.

    The average price target for ACAD by Institutional Analysts is $30.03, which is 45.69% Upside from the current price. So according to the Institutional Analysts, ACAD Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Acadia Pharmaceuticals Inc (ACAD) Stock Forecast Based on Investor Sentiment


    Very Positive

    Based on 388,226 investor portfolio.

    Our algorithm has analysed 388,226 investor portfolio with ACAD stock holdings and found that 99.50% of them are bullish. Which means the Investor Sentiment is mostly Very Positive.

    This shows most investors are very optimistic about ACAD and holding their positions hoping for a further rise in the stock price and more profit.

    Acadia Pharmaceuticals Inc (ACAD) Stock Forecast Based on News Sentiment


    Bearish
    Based on 24 articles published Last Week, where 0.00% are Bullish and 100.00% are Bearish.

    According to the news articles published last week, most journalists and bloggers talked negatively about ACAD, it shows that Acadia Pharmaceuticals Inc had a 100.00% negative news coverage.

    Negative news coverage usually affects short-term price of a stock, so this negative coverage provides an indication that ACAD stock price may go down in the next few weeks.

    Acadia Pharmaceuticals Inc (ACAD) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    HC Wainwright & Co.NeutralDowngraded
    Morgan StanleyOverweightMaintained
    MizuhoNeutralDowngraded
    JefferiesHoldDowngraded
    Goldman SachsNeutralDowngraded
    Canaccord GenuityHoldDowngraded
    NeedhamBuyMaintained
    B of A SecuritiesNeutralDowngraded
    StifelHoldDowngraded
    Raymond JamesOutperformDowngraded
    NeedhamBuyMaintained
    Morgan StanleyOverweightMaintained
    HC Wainwright & Co.BuyMaintained
    GuggenheimNeutralDowngraded
    CitigroupNeutralDowngraded
    Canaccord GenuityBuyMaintained
    Morgan StanleyOverweightMaintained
    Morgan StanleyOverweightMaintained
    MizuhoBuyInitiated
    Raymond JamesStrong BuyUpgraded
    Morgan StanleyOverweightMaintained
    Morgan StanleyOverweightMaintained
    Raymond JamesOutperformInitiated
    Morgan StanleyOverweightInitiated
    SVB LeerinkOutperformMaintained
    Canaccord GenuityBuyMaintained
    RBC CapitalOutperformMaintained
    OppenheimerPerformMaintained
    Cantor FitzgeraldOverweightMaintained
    StifelBuyUpgraded
    OppenheimerPerformMaintained
    JP MorganOverweightMaintained
    Cantor FitzgeraldOverweightReiterated
    JefferiesBuyInitiated
    Goldman SachsBuyUpgraded
    CitigroupBuyInitiated
    JP MorganNeutralMaintained
    Cantor FitzgeraldOverweightReiterated
    Guggenheim SecuritiesBuyInitiated
    Cantor FitzgeraldOverweightReiterated
    JP MorganNeutralMaintained
    OppenheimerPerformInitiated
    RBC CapitalOutperformInitiated
    Cantor FitzgeraldOverweightMaintained
    SVB LeerinkOutperformUpgraded
    Canaccord GenuityBuyUpgraded
    NeedhamBuyMaintained
    Stifel NicolausHoldMaintained
    Cantor FitzgeraldOverweightReiterated
    Raymond JamesStrong BuyReiterated
    Canaccord GenuityHoldInitiated
    UBSNeutralInitiated
    Leerink SwannMarket PerformInitiated
    Leerink SwannMarket PerformInitiated
    Cantor FitzgeraldOverweightMaintained
    Cantor FitzgeraldOverweightMaintained
    Bank of AmericaBuyMaintained
    PiperJaffrayOverweightUpgraded
    Cantor FitzgeraldOverweightInitiated
    Stifel NicolausHoldMaintained
    JMP SecuritiesMarket OutperformMaintained
    Stifel NicolausHoldInitiated
    PiperJaffrayNeutralDowngraded
    Goldman SachsNeutralInitiated
    Bank of AmericaBuyUpgraded
    Leerink SwannMarket PerformInitiated
    Bank of AmericaNeutralDowngraded
    Leerink SwannMarket PerformDowngraded
    JP MorganNeutralMaintained
    Bank of AmericaBuyInitiated
    PiperJaffrayOverweightUpgraded
    Leerink SwannOutperformMaintained
    PiperJaffrayNeutralDowngraded
    JP MorganOverweightMaintained
    JP MorganOverweightMaintained
    Leerink SwannOutperformInitiated
    JefferiesBuyMaintained
    JMP SecuritiesMarket OutperformMaintained
    H.C. WainwrightBuyInitiated
    JefferiesBuyMaintained
    Cowen & Co.OutperformInitiated
    JP MorganOverweightInitiated
    McNicoll Lewis VlakHoldDowngraded
    JMP SecuritiesMarket OutperformMaintained
    JefferiesBuyMaintained
    Roth CapitalBuyMaintained
    PiperJaffrayOverweightUpgraded
    McNicoll Lewis VlakBuyMaintained
    McNicoll Lewis VlakBuyMaintained
    JefferiesBuyInitiated
    Cowen & Co.OutperformInitiated
    NeedhamBuyUpgraded
    Ladenburg ThalmannBuyInitiated

    Acadia Pharmaceuticals Inc (ACAD) Stock Earning Per Share (EPS) Forecast / Estimate


    $-0.525
    The average consensus EPS for ACAD is $-0.525 with a high estimate of $-0.367 and Low of $-0.755 for the period 2021-06-30 and based on 21 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $-0.54$-0.39099662020-09-30


    The latest average Earning Per Share Estimate for Acadia Pharmaceuticals Inc is $-0.52, which is higher than ACAD's last EPS, $-0.54. This means that Analysts are expecting Acadia Pharmaceuticals Inc to report higher earnings. This can drive share prices higher since the investors have positive sentiment about market performance of Acadia Pharmaceuticals Inc.

    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $-0.54$-0.39099662020-09-30
    $-0.27$-0.45128882020-06-30
    $-0.57$-0.48989582020-03-31
    $-0.34$-0.370117200000000042019-12-31
    $-0.29$-0.40957082019-09-30
    $-0.38$-0.4636412019-06-30
    $-0.59$-0.5350412019-03-31
    $-0.5$-0.5612018-12-31
    $-0.5$-0.589562018-09-30
    $-0.51$-0.46126442018-06-30
    $-0.44$-0.55954142018-03-31
    $-0.55$-0.58707122017-12-31
    $-0.53$-0.636482017-09-30
    $-0.55$-0.73439999999999992017-06-30
    $-0.72$-0.74912882017-03-31
    $-0.65$-0.6632016-12-31
    $-0.61$-0.57122016-09-30
    $-0.63$-0.49982016-06-30
    $-0.45$-0.42726782016-03-31
    $-0.45$-0.38873222015-12-31
    $-0.39$-0.408000000000000032015-09-30
    $-0.39$-0.33433562015-06-30
    $-0.4$-0.275400000000000032015-03-31
    $-0.28$-0.26067122014-12-31
    $-0.25$-0.22148282014-09-30
    $-0.22$-0.195503400000000022014-06-30
    $-0.19$-0.13262014-03-31
    $-0.13$-0.137700000000000022013-12-31
    $-0.12$-0.1236752013-09-30
    $-0.11$-0.089252013-06-30
    $-0.08$-0.08386442013-03-31
    $-0.11$-0.0930752012-12-31
    $-0.04$-0.08499662012-09-30
    $-0.1$-0.12410342012-06-30
    $-0.12$-0.108803400000000012012-03-31
    $-0.1$-0.102000000000000012011-12-31
    $-0.1$-0.102000000000000012011-09-30
    $-0.12$-0.14282011-06-30
    $-0.12$-0.112200000000000012011-03-31
    $0.74$0.70719660000000012010-12-31

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).